The Haemato-oncology research groups are working together across six themes to better understand haematological malignancies. Scientists benefit from access to high-quality infrastructure and access to a broad range of processed samples through our Bone Marrow Failure Tissue Bank. Our research focuses on the identification of genetic changes and molecular signatures of haematological proliferation to further develop and test novel interventions and immunotherapies in patients.
Through our collaborations with King’s College Hospital (KCH) and under the umbrella of King’s Health Partners (KHP), we ensure that our research portfolio is both, closely aligned to the NHS and maximises patient benefit.
Read more about the work of each of the groups in the left menu.